Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Erythrosin B

FDA product code KJR · 3 cleared devices

Class 1 Hematology
Regulation
21 CFR 864.1850
Review panel
PA
Implant
No
Life sustaining
No
Third party review
No
GMP exempt
Yes
Clearance span
1979-12-18 – 1984-08-28
↑